BCAB Competitors & Alternatives
Compare Bioatla Inc with similar stocks in the same industry
Biotechnology
BCAB
Main Stock$3.71
Tradestie Score
51
Market Cap
$39.57M
Revenue Growth
0.3%
Analyst Upside
+169.5%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACRS
Aclaris Therapeutics, Inc.
|
$5.02
|
$202.58M | - | 56 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$17.88
|
$170.45M | - | 59 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$4.91
|
$158.43M | - | 51 | Compare |
|
CCCC
C4 Therapeutics, Inc.
|
$4.45
|
$153.02M | - | 58 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.25
|
$133.50M | - | 64 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.43
|
$114.01M | - | 55 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$23.39
|
$110.20M | - | 60 | Compare |
|
ALXO
ALX Oncology Holdings Inc. Common Stock
|
$1.66
|
$96.93M | - | 51 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.92
|
$71.69M | - | 58 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.16
|
$67.94M | - | 56 | Compare |
More BCAB Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2836)
224 stocks in this industry